Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H20O12 |
| Molecular Weight | 464.3763 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H]1O[C@@H](OC2=C(OC3=CC(O)=CC(O)=C3C2=O)C4=CC(O)=C(O)C=C4)[C@H](O)[C@@H](O)[C@@H]1O
InChI
InChIKey=OVSQVDMCBVZWGM-QSOFNFLRSA-N
InChI=1S/C21H20O12/c22-6-13-15(27)17(29)18(30)21(32-13)33-20-16(28)14-11(26)4-8(23)5-12(14)31-19(20)7-1-2-9(24)10(25)3-7/h1-5,13,15,17-18,21-27,29-30H,6H2/t13-,15-,17+,18-,21+/m1/s1
| Molecular Formula | C21H20O12 |
| Molecular Weight | 464.3763 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Isoquercetin is a flavonoid, derivative of quercetin. It was isolated from various plant species including Ammothamnus Lehmanii, Caragana alaica, Cicer baldshuanicum, C. macroconthum, C. pungens, Euphorbia cyparissias, E. helioscapia, E. lathyris, E. lucida, E. purporata and others. It demonstrated radical scavenging activity, inhibitory effects on Na+/K+-ATPase and positive inotropic activity. It is protein disulfide isomerase (PDI) inhibitor. As a PDI inhibitor, this agent blocks PDI-mediated platelet activation, and fibrin generation, which prevents thrombus formation after vascular injury. Isoquercetin inhibited the replication of both influenza A and B viruses at the lowest effective concentration. Isoquercetin activates the ERK1/2-Nrf2 pathway and protects against cerebral ischemia-reperfusion injury in vivo and in vitro. It is being investigated for prevention of thromboembolism in selected cancer patients and as an anti-fatigue agent in kidney cancer patients treated with sunitinib.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: WP402 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28413477 |
|||
Target ID: CHEMBL2095186 Sources: DOI: 10.1007/978-1-4614-0535-1_485 |
|||
Target ID: CHEMBL5422 |
2.5 µM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Preventing | Unknown Approved UseUnknown |
|||
| Secondary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effect of enzymatically modified isoquercitrin on preneoplastic liver cell lesions induced by thioacetamide promotion in a two-stage hepatocarcinogenesis model using rats. | 2013-03-08 |
|
| Screening medicinal plants for the detection of novel antimalarial products applying the inhibition of β-hematin formation. | 2011-12-15 |
|
| Concomitant apoptosis and regeneration of liver cells as a mechanism of liver-tumor promotion by β-naphthoflavone involving TNFα-signaling due to oxidative cellular stress in rats. | 2011-04-28 |
|
| Phenolic compounds in leaves of Alchornea triplinervia: anatomical localization, mutagenicity, and antibacterial activity. | 2010-08 |
|
| [Flavonoids of Lysimachia paridiformis var. stenophylla]. | 2010-07 |
|
| [Flavonoids and phenolic acid derivatives from flos farfarae]. | 2010-05 |
|
| [Glycosides from Periploca forrestii]. | 2010-03 |
|
| Antioxidant enzymatically modified isoquercitrin suppresses the development of liver preneoplastic lesions in rats induced by beta-naphthoflavone. | 2010-02-09 |
|
| Antioxidant enzymatically modified isoquercitrin or melatonin supplementation reduces oxidative stress-mediated hepatocellular tumor promotion of oxfendazole in rats. | 2010-02 |
|
| Who is the king? The alpha-hydroxy-beta-oxo-alpha,beta-enone moiety or the catechol B ring: relationship between the structure of quercetin derivatives and their pro-oxidative abilities. | 2010-01 |
|
| Preparative isolation and purification of four flavonoids from the petals of Nelumbo nucifera by high-speed counter-current chromatography. | 2009-12-19 |
|
| [Chemical constituents in Buddleja albiflora]. | 2009-12 |
|
| [Chemical constituents of Galium verum]. | 2009-11 |
|
| Nondigestible saccharides suppress the bacterial degradation of quercetin aglycone in the large intestine and enhance the bioavailability of quercetin glucoside in rats. | 2009-10-28 |
|
| [Chemical constituents from leaves of Sterculia foetida]. | 2009-10 |
|
| [Flavones from Helichrysi flos syn]. | 2009-06 |
|
| [Chemical constituents from Neo-Taraxacum siphonathum]. | 2009-04 |
|
| [Chemical study on ethyl acetate soluble portion of Kadsura oblongifolia]. | 2009-04 |
|
| [Study on chemical constituents of Herba Cirsii]. | 2009-01 |
|
| [Flavonoid constituents from herbs of Sarcopyramis bodinieri var. delicata]. | 2009-01 |
|
| Chemical composition of the stem bark and leaves of Ficus pandurata Hance. | 2009 |
|
| Phytochemicals of apple peels: isolation, structure elucidation, and their antiproliferative and antioxidant activities. | 2008-11-12 |
|
| [Flavones from flowers of Paulownia fortunei]. | 2008-11 |
|
| Flavonoid glycosides isolated from Salicornia herbacea inhibit matrix metalloproteinase in HT1080 cells. | 2008-10 |
|
| Light filtering by epidermal flavonoids during the resistant response of cotton to Xanthomonas protects leaf tissue from light-dependent phytoalexin toxicity. | 2008-09 |
|
| Deep supercooling xylem parenchyma cells of katsura tree (Cercidiphyllum japonicum) contain flavonol glycosides exhibiting high anti-ice nucleation activity. | 2008-09 |
|
| Taxodione, a DNA-binding compound from Taxodium distichum L. (Rich.). | 2008-08-02 |
|
| Soil quality effects on Chenopodium album flavonoid content and antioxidant potential. | 2008-07-09 |
|
| [Chemical constituents from Polygonum capitatum and their antioxidation activities in vitro]. | 2008-07 |
|
| Determination of quercetin and its glucosides in onion by electrochemical methods. | 2008-06-09 |
|
| Determination of the relative contribution of quercetin and its glucosides to the antioxidant capacity of onion by cyclic voltammetry and spectrophotometric methods. | 2008-05-28 |
|
| Pharmacological basis for use of Pistacia integerrima leaves in hyperuricemia and gout. | 2008-05-22 |
|
| Camellia japonica suppresses immunoglobulin E-mediated allergic response by the inhibition of Syk kinase activation in mast cells. | 2008-05 |
|
| [Study on antioxidant activity of constituents from mulberry leaf]. | 2008-04 |
|
| Deconjugation and degradation of flavonol glycosides by pig cecal microbiota characterized by Fluorescence in situ hybridization (FISH). | 2008-03-26 |
|
| [Studies on chemical constituents of Arachniodes rhomboidea]. | 2008-03 |
|
| Quercetin 3-glucoside protects neuroblastoma (SH-SY5Y) cells in vitro against oxidative damage by inducing sterol regulatory element-binding protein-2-mediated cholesterol biosynthesis. | 2008-01-25 |
|
| [Studies on chemical constituents of Primula sikkmensis]. | 2008-01 |
|
| Three new 3-benzylbenzofuran-2-one derivatives from Homalium brachybotrys (Flacourtiaceae/Salicaceae s. l.). | 2007-11 |
|
| [Isolation and preparation of flavones from the leaves of Lindera aggregata using high speed counter-current chromatography]. | 2007-09 |
|
| [Studies on antiproliferative effect of flavones compounds isolated from Yao herb medicines]. | 2007-08 |
|
| An unusual C6-C6" linked flavonoid from Miconia cabucu (Melastomataceae). | 2007-07 |
|
| The anti-thrombotic active constituents from Centella asiatica. | 2007-05 |
|
| Simultaneous determination of seven flavonoids in Potentilla multifida by HPLC. | 2007-04 |
|
| Development of an HPLC-PAD-MS assay for the identification and quantification of major phenolic edelweiss (Leontopodium alpium Cass.) constituents. | 2006-10-06 |
|
| Constituents from the leaves of Phellodendron amurense and their antioxidant activity. | 2006-09 |
|
| Quantitative determination of major active components in Ginkgo biloba dietary supplements by liquid chromatography/mass spectrometry. | 2006 |
|
| [Study on chemical constituents of Lagotis yunnanensis]. | 2005-09 |
|
| Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase. | 1995-04 |
|
| Inhibition of HIV infection by flavanoids. | 1993-10 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT02195232
500 mg or 1000 mg, Once daily, 28 days
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28413477
The protein expression of Nrf2 in rat hippocampal neurons in the 100 ug/ml group increased by 200% compared with the OGD/R (oxygen-glucose deprivation followed by reoxygenation) group.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:13:23 GMT 2025
by
admin
on
Mon Mar 31 19:13:23 GMT 2025
|
| Record UNII |
6HN2PC637T
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C68457
Created by
admin on Mon Mar 31 19:13:23 GMT 2025 , Edited by admin on Mon Mar 31 19:13:23 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
28299
Created by
admin on Mon Mar 31 19:13:23 GMT 2025 , Edited by admin on Mon Mar 31 19:13:23 GMT 2025
|
PRIMARY | |||
|
115918
Created by
admin on Mon Mar 31 19:13:23 GMT 2025 , Edited by admin on Mon Mar 31 19:13:23 GMT 2025
|
PRIMARY | |||
|
5280804
Created by
admin on Mon Mar 31 19:13:23 GMT 2025 , Edited by admin on Mon Mar 31 19:13:23 GMT 2025
|
PRIMARY | |||
|
DTXSID3041110
Created by
admin on Mon Mar 31 19:13:23 GMT 2025 , Edited by admin on Mon Mar 31 19:13:23 GMT 2025
|
PRIMARY | |||
|
6HN2PC637T
Created by
admin on Mon Mar 31 19:13:23 GMT 2025 , Edited by admin on Mon Mar 31 19:13:23 GMT 2025
|
PRIMARY | |||
|
C110309
Created by
admin on Mon Mar 31 19:13:23 GMT 2025 , Edited by admin on Mon Mar 31 19:13:23 GMT 2025
|
PRIMARY | |||
|
68352
Created by
admin on Mon Mar 31 19:13:23 GMT 2025 , Edited by admin on Mon Mar 31 19:13:23 GMT 2025
|
PRIMARY | |||
|
482-35-9
Created by
admin on Mon Mar 31 19:13:23 GMT 2025 , Edited by admin on Mon Mar 31 19:13:23 GMT 2025
|
PRIMARY | |||
|
C117288
Created by
admin on Mon Mar 31 19:13:23 GMT 2025 , Edited by admin on Mon Mar 31 19:13:23 GMT 2025
|
PRIMARY | |||
|
ISOQUERCETIN
Created by
admin on Mon Mar 31 19:13:23 GMT 2025 , Edited by admin on Mon Mar 31 19:13:23 GMT 2025
|
PRIMARY | |||
|
300000017646
Created by
admin on Mon Mar 31 19:13:23 GMT 2025 , Edited by admin on Mon Mar 31 19:13:23 GMT 2025
|
PRIMARY | |||
|
m6537
Created by
admin on Mon Mar 31 19:13:23 GMT 2025 , Edited by admin on Mon Mar 31 19:13:23 GMT 2025
|
PRIMARY | Merck Index | ||
|
DB12665
Created by
admin on Mon Mar 31 19:13:23 GMT 2025 , Edited by admin on Mon Mar 31 19:13:23 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
CALENDULA OFFICINALIS FLOWER Flavonoid
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Secondary metabolite detected in developing cacao seeds.
|